ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $393,800 | -70.1% | 44,598 | -74.1% | 0.01% | -79.0% |
| Q4 2022 | $1,317,029 | +339.0% | 172,386 | +308.9% | 0.06% | +520.0% |
| Q3 2022 | $300,000 | -18.7% | 42,161 | -6.2% | 0.01% | -9.1% |
| Q2 2022 | $369,000 | -38.1% | 44,935 | +4.6% | 0.01% | -8.3% |
| Q1 2022 | $596,000 | -50.7% | 42,947 | +0.7% | 0.01% | -50.0% |
| Q4 2021 | $1,208,000 | -27.6% | 42,654 | -17.0% | 0.02% | -22.6% |
| Q3 2021 | $1,668,000 | -4.5% | 51,399 | +24.2% | 0.03% | +10.7% |
| Q2 2021 | $1,746,000 | +8.7% | 41,385 | -3.1% | 0.03% | -3.4% |
| Q1 2021 | $1,606,000 | -42.5% | 42,727 | -9.1% | 0.03% | -52.5% |
| Q4 2020 | $2,792,000 | +17.2% | 47,008 | -5.3% | 0.06% | -19.7% |
| Q3 2020 | $2,383,000 | +188.1% | 49,614 | +176.3% | 0.08% | +162.1% |
| Q2 2020 | $827,000 | – | 17,955 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |